• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Chroma Medicine

Three tacos on a white countertop with lime slices next to them
Biotech

2 biotechs shed staff, fuse to form genetic medicine company

Chroma Medicines and Nvelop Therapeutics are fusing their names and science to launch nChroma Bio, with the backing of a $75M fundraising round.
Darren Incorvaia Dec 11, 2024 7:00am
parasail Blue Lagoon parachute

CRISPR Tx, Novartis, Cour & more—Chutes & Ladders

May 24, 2024 8:30am
Dnmt1

Epigenetic silencing lasts in mice, Chroma-sponsored study shows

Feb 28, 2024 11:00am
The silhouette of a miner digging

Hepatitis B drug developers chart slow progress, just like hep C

Nov 14, 2023 9:05am
Photo of a lever outside that indicates turning something on or off

Chroma bags $135M to bolster epigenetic-focused platform

Feb 28, 2023 6:10pm
Thomas Cahill

After Chroma and Prime, Newpath lines up $350M for 8-12 biotechs

Dec 8, 2021 6:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings